445
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Early intervention in schizophrenia in developing countries: Focus on duration of untreated psychosis and remission as a treatment goal

, &
Pages 483-488 | Received 07 May 2012, Accepted 16 Jun 2012, Published online: 12 Oct 2012

References

  • Andreasen, N.C., Carpenter, W.T., Kane, J.M., Lasser, R.A., Marder, S.R. & Weinberger, D.R. (2005). Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441–449.
  • Birchwood, M., Todd, P. & Jackson C. (1998). Early intervention in psychosis. The critical period hypothesis. British Journal of Psychiatry, 72, 53–59.
  • Bosanac, P., Patton, G.C. & Castle, D.J. (2010). Early intervention in psychotic disorders: Faith before facts?Psychological Medicine, 40, 353–358.
  • Brietzke, E., Araripe Neto, A.G., Dias, A., Mansur, R.B. & Bressan, R.A. (2011). Early intervention in psychosis: A map of clinical and research initiatives in Latin America. Revista Brasileira de Psiquiatria, 33, S213–224.
  • Burns, J.K., Jhazbhay, K. & Emsley, R.A. (2010). Causal attributions, pathway to care and clinical features of first-episode psychosis: A South African perspective. International Journal of Social Psychiatry, 57, 538–545.
  • Chen, E.Y., Wong, G.H., Lam, M.M., Chiu, C.P. & Hui, C.L. (2008). Real-world implementation of early intervention in psychosis: Resources, funding models and evidence-based practice. World Psychiatry, 7, 163–164.
  • Emsley, R., Oosthuizen, P.P., Kidd, M., Koen, L., Niehaus, D.J. & Turner, H.J. (2006). Remission in first-episode psychosis: Predictor variables and symptom improvement patterns. Journal of Clinical Psychiatry, 67, 1707–12.
  • Emsley, R., Oosthuizen, P., Koen, L., Niehaus, D.J., Medori, R. & Rabinowitz, J. (2008b). Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies. Clinical Therapeutics, 30, 2378–2386.
  • Emsley, R., Oosthuizen, P., Koen, L., Niehaus, D.J., Medori, R. & Rabinowitz, J. (2008a). Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: A study with risperidone long-acting injection. International Clinical Psychopharmacology, 23, 325–331.
  • Farooq, S., Large, M., Nielssen, O. & Waheed, W. (2009). The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: A systematic review and meta analysis. Schizophrenia Research, 109, 15–23.
  • Green, A.I., Lieberman, J.A., Hamer, R.M., Glick, I.D., Gur, R.E., Kahn, R.S., Zipursky, R.B. (2006). Olanzapine and haloperidol in first episode psychosis: Two-year data. Schizophrenia Research, 86, 234–243.
  • Iyer, S.N., Mangala, R., Thara, R. & Malla, A.K. (2010). Preliminary findings from a study of first-episode psychosis in Montreal, Canada and Chennai, India: Comparison of outcomes. Schizophrenia Research, 121, 227–233.
  • Keshavan, M.S., Shrivastava, A. & Gangadhar, B.N. (2010). Early intervention in psychotic disorders: Challenges and relevance in the Indian context. Indian Journal of Psychiatry, 52, S153–158.
  • Kurihara, T., Kato, M., Reverger, R. & Tirta, I.G.R., (2011a). Remission in schizophrenia: A community-based 6-year follow-up study in Bali. Psychiatry and Clinical Neurosciences, 65, 476–482.
  • Kurihara, T., Kato, M., Reverger, R. & Tirta, I.G.R. (2011b)Seventeen-year clinical outcome of schizophrenia in Bali. European Psychiatry, 26, 333–338.
  • Large, M., Farooq, S. & Nielssen, O. (2008). Duration of untreated psychosis in low and middle income countries: The relationship between GDP and DUP. British Journal of Psychiatry, 193, 272–278.
  • Lieberman, J.A., Phillips, M., Gu, H., Stroup, S., Zhang, P., Kong, L., Hamer, R.M. (2003). Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: A 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology, 28, 995–1003.
  • Malla, A.K., Norman, R.M., Manchanda, R., McLean, T.S., Harricharan, R., Cortese, L., Scholten, D.J. (2002). Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment. Psychiatric Services, 53, 458–463.
  • Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P. & Croudace, T. (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Archives of General Psychiatry, 62, 975–983.
  • McGlashan, TH. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course?Biological Psychiatry, 46, 899–907.
  • McGorry, P.D., Killackey, E. & Yung, A. (2008). Early intervention in psychosis: Concepts, evidence and future directions. World Psychiatry, 7, 148–156.
  • Naqvi, H.A., Hussain, S., Zaman, M. & Islam, M. (2009). Pathways to care: Duration of untreated psychosis from Karachi, Pakistan. PLoS ONE, 4, e7409.
  • Ndetei, D.M. (2008). Early intervention in psychosis: Concepts, evidence and perspectives. World Psychiatry, 7, 164–165.
  • Oliveira, A.M., Menezes, P.R., Busatto, G.F., McGuire, P.K., Murray, R.M. & Scazufca, M. (2010). Family context and duration of untreated psychosis (DUP): Results from the Sao Paulo Study. Schizophrenia Research, 119, 124–130.
  • Perkins, D.O., Gu, H., Boteva, K. & Lieberman, J.A. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry, 162, 1785–1804.
  • Rice, D.P. (1999). The economic impact of schizophrenia. Journal of Clinical Psychiatry, 60, 4–6.
  • Rössler, W., Salize, H.J., van Os, J. & Riecher-Rössler, A. (2005). Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology, 15, 399–409.
  • Saravanan, B., Jacob, K.S., Johnson, S., Prince, M., Bhugra, D., David, A.S. (2010). Outcome of first-episode schizophrenia in India: Longitudinal study of effect of insight and psychopathology. British Journal of Psychiatry, 196, 454–459.
  • Schooler, N., Rabinowitz, J., Davidson, M., Emsley, R., Harvey, P.D., Kopala, L. Early Psychosis Global Working Group, (2005). Risperidone and haloperidol in first episode psychosis: A long-term randomized trial. American Journal of Psychiatry, 162, 947–953.
  • Sharifi, V., Kermani-Ranjbar, T., Amini, H., Alaghband-rad, J., Salesian, N. & Seddigh, A. (2009). Duration of untreated psychosis and pathways to care in patients with first-episode psychosis in Iran. Early Intervention in Psychiatry, 3, 131–136.
  • Thirthalli, J., Channaveerachari, N.V., Subbakrishna, D.K., Cottler, L.B., Varghese, M. & Gangadhar, B.N. (2011). Prospective study of duration of untreated psychosis and outcome of never-treated patients with schizophrenia in India. Indian Journal of Psychiatry, 53, 319–323.
  • Uçok, A., Serbest, S. & Kandemir, P.E. (2011). Remission after first-episode schizophrenia: Results of a long-term follow-up. Psychiatry Research, 189, 33–37.
  • van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Kane, J.M. (2006). Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica, 113, 91–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.